Initiative for Theranostics and Particle Therapy
The Initiative for Theranostics and Particle Therapy (ITPT) is a joint initiative of UW Carbone, UW School of Medicine and Public Health, Wisconsin Alumni Research Foundation and UW Health to strengthen existing research collaborations, create new partnerships and resources, and drive innovative treatments for metastatic cancer patients in Wisconsin and worldwide.
ITPT unites the efforts of researchers whose specialties include targeted radionuclide therapy (TRT) discovery and development, radiobiology, translational radiotherapy, medical physics, advanced imaging, personalized dosimetry, and radio-immunotherapy combinations. In addition to cross-training and educational goals, ITPT resources will support preclinical, translational and clinical research to advance new precision radiopharmaceutical development.
Upcoming Events
November
-
November 17UW Carbone Initiative for Theranostics & Particle Therapy SeminarGuest speaker: LisaAnn Trembath3:30 PM, Health Sciences Learning Center
June
-
June 2
-
June 3
Leadership
Education and Training Subcommittee
Education and Training Subcommittee
Education and Training Subcommittee
Education and Training Subcommittee
Clinical Research and Practice Subcommittee
Discovery and Translational Subcommittee
Clinical Research and Practice Subcommittee
Clinical Research and Practice Subcommittee
Clinical Research and Practice Subcommittee
Discovery and Translational Subcommittee
RASR Lab
ITPT oversees the Radiopharmaceutical Analytics and Specimen Research (RASR) laboratory. RASR enables UW Carbone researchers and external partners to store and analyze radioactive tissue samples and thoroughly examine the in vivo metabolism and biology of radiopharmaceuticals. The operational aim of the RASR is to harbor all radioactive analyses within the ITPT in order to streamline regulatory requirements and compliance while maximizing safety. RASR is a secure facility with access limited to approved researchers and staff. RASR equipment that enables state-of-the-art immunophenotyping of radioactive blood and tissues specimens. See full equipment list on their site.
